© 2018 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Scientists aren’t sure, but they know that the risk that a previous case of liver cancer will return remains high for those cured of hep C.
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease.
Latonya Wilson advocates for better understanding of metastatic breast cancer and more outreach to African Americans.
We asked the experts what they think will be the next big breakthroughs.
Could other patients’ bodies be taught to do the same thing?
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives.
Stigma affects access to treatment, research funding, public empathy and support for all people with lung cancer.
Scalp cooling technology can prevent hair loss caused by cancer treatment.
Researchers are working to discover why immunotherapies succeed or fail.
How researchers are tweaking engineered immune cells’ cancer-targeting receptors—and why it matters.
‘Many reasons for optimism’ says expert at annual community symposium.
Two years later, Michael Mullan’s cancer is still at bay because of immunotherapy and targeted chemotherapy.
A recent report suggests reduced screening may be linked to a rise in advanced disease.
The Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration.
Federal limits on research hinder patients’ relief
Are portals delivering on their promise—or are results too often a source of confusion and alarm?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
